These are the FTSE 100’s 5 worst performers over a year. Do you own them?

The FTSE 100 is up 14% in the past 12 months. Sadly, these five Footsie dogs have seen their share prices dive by up to 21%, but I like three of them today.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

UK investors have done pretty well in 2021. With the FTSE 100 index hovering around 7,085 points, it has gained around 625 points this calendar year. That’s an uplift of nearly a tenth (9.7%) in six months. Also, over the past 12 months, while some individual FTSE 100 shares have done brilliantly, others are in the doghouse.

FTSE 100 winners and losers

In the year since 29 June 2020, the FTSE 100 has gained almost 860 points. That’s an uplift of more than an eighth (13.8%) over 12 months. Of 101 stocks in the Footsie (one is dual-listed), 87 have risen in value over a year. Gains among these winners range from 269.4% to 0.6%. The average increase across all 87 gainers is 37.7% (almost two-fifths). This leaves us with the FTSE 100’s 14 losers. Losses among these losers range from 0.2% to 20.8%. The average loss across these 14 decliners is 6.7%. That’s around 20 percentage points lower than the index return. Ouch.

The Footsie’s five biggest dogs

These are the FTSE 100’s five worst-performing shares over the past 12 months:

British American Tobacco (Tobacco)

Reckitt Benckiser Group (Consumer goods) -10.6%
DCC (Support services) -12.1%
GlaxoSmithKline (Healthcare) -14.1%
Just Eat (Online delivery) -20.8%

Losses among these FTSE 100 dogs range from almost a tenth (-9.5%) at cigarette maker BAT to over a fifth (-20.8%) at food delivery firm JET. I wonder how many of these stocks you own, either individually or inside FTSE 100-focused funds? If you’re feeling down about owning any of these losers, take some comfort from this thought. My largest individual shareholding (and my family’s) is in GlaxoSmithKline — 100/101 in this Footsie ranking. What’s more, I’ve been a GSK shareholder for decades, with some pretty mixed outcomes at times.

I’d buy three of these five dogs today

As an income-seeking value investor, I hunt for bombed-out, unloved, and undervalued FTSE 100 stocks to add to my family portfolio. Currently, GSK shares offer a dividend yield of nearly 5.7% a year (around two percentage points higher than the Footsie’s yield). However, the 80p dividend will be cut to 55p in 2022 and could go lower or higher in 2023. Even so, I will hang onto my GSK shares, using their tasty quarterly dividends to boost my portfolio returns.

I’m also a fan of £45.8bn FMCG (fast-moving consumer goods) giant Reckitt Benckiser. I’ve been watching Reckitt grow rapidly this millennium, rising from a share price of £5 in 2000 to today’s heights around £65. This FTSE 100 firm had a great 2020, as sales of cleansing and hygiene products soared during Covid-19. The shares offer a dividend yield of 2.7%, which could rise over time. I don’t own shares in RB, but I see it as a good business with decent growth potential, so I’d buy at current price levels.

Third, tobacco stocks generate some of the FTSE 100’s highest cash dividends to shareholders. At the current share price around 2,820p, BAT offers a mouth-watering dividend yield of 7.6% a year. I don’t own BAT at present, but I’d happily buy and hold this FTSE 100 stock to watch my fat dividends roll in. Finally, one word of warning: as a veteran income investor, I know only too well that company dividends are not guaranteed. They can be cut, suspended, or cancelled at any point, which happened big-time in 2020. Therefore, never rely solely on dividends for all of your income!

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Cliffdarcy owns shares of GlaxoSmithKline. The Motley Fool UK has recommended British American Tobacco, GlaxoSmithKline, and Just Eat N.V. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services, such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool, we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Young Black woman looking concerned while in front of her laptop
Investing Articles

The IAG share price is dirt cheap and profits are flying. So why am I worried?

After today's positive full-year results, I expected the International Consolidated Airlines Group (IAG) share price to be doing better than…

Read more »

Investing Articles

Is Tesla stock a steal below $200?

Tesla stock has fallen 19% so far in 2024. Currently hovering around $200, this Fool checks if now is the…

Read more »

Investing Articles

3 high-yield dividend stocks to consider for my passive income portfolio in 2024

I want to build a portfolio of dividend stocks that pay enough passive income to retire comfortably. Here are my…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

Direct Line shares soar 25% on takeover bid!

Direct Line shares surged by a quarter on Wednesday, after receiving a takeover bid from a Belgian rival. But the…

Read more »

Investing Articles

Will it be too late to buy Nvidia stock in March?

NVIDIA stock is up more than 60% since the start of 2024. Our writer considers whether it might still be…

Read more »

Typical street lined with terraced houses and parked cars
Investing Articles

Why did Direct Line shares just soar 27%?

Direct Line shares have jumped more than a quarter in the course of today's trading session. Our writer explains why…

Read more »

Close-up of British bank notes
Investing Articles

These 2 shares are Dividend Aristocrats. Which should I buy this March?

Our writer likes the business model of this pair of FTSE 100 Dividend Aristocrats. So why would he only consider…

Read more »

Frustrated young white male looking disconsolate while sat on his sofa holding a beer
Investing Articles

I bought 49 Unilever shares in June. Here’s what they’re worth today

Harvey Jones bought a modest amount of Unilever shares last summer hoping the stock would soon recover. He's having to…

Read more »